Emerging disease information at your fingertips.
Actions Requested COVID-19 Be aware, emergency use of the Novavax COVID-19 vaccine was authorized as a two-dose primary series in individuals 12 through 17 years of age on August 19, 2022 by the U.S. Food & Drug Administration. They analyzed the vaccine in this age group and found it to be safe and effective. The … Health Advisory: COVID-19 and Monkeypox Update for Providers
Click here to access the latest Kitsap Respiratory Illness Report: 07.17.22 – 08.13.22.
August 24, 2022 Actions Requested Clinicians should suspect Monkeypox virus infection in any patient presenting with one or more lesions that suggest monkeypox infection, regardless of the patient’s age, social history, gender, or sexual identity. Recently, the first cases of monkeypox in cisgender adult females and an adolescent under the age of 18 were reported in … Health Advisory: Monkeypox Update